Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology

鞘脂、膳食脂肪酸和肠道病理生理学

基本信息

  • 批准号:
    10532716
  • 负责人:
  • 金额:
    $ 33.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-12-01 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

Diets high in fat have been linked to obesity, and a high fat diet (HFD) has been implicated in altering intestinal function, including inflammation; however, the contribution of specific HFDs and their predominant fatty acids (FAs) on key pathophysiologic processes is largely unknown. Studies with trans-fats, lard, olive oil, fish oil, plant- based fats (corn oil, soybean, etc.) have demonstrated that specific sources of FAs exert extremely diverse effects in disease, most commonly in cardiac and metabolic disease. Therefore, the long-term goal of this proposal is to dissect the complexity of components and effects of specific dietary FAs on gut pathobiology and determine the mechanisms involved. Specifically, we aim to define the specific roles of two ceramide-generating enzymes, ceramide synthases (CerS) 5 and 6, in the regulation of myristate-induced activation of inositol requiring enzyme 1α (IRE1α) and define their critical roles in intestinal homeostasis and pathophysiology. IRE1α is a critical branch in the unfolded protein response (UPR) or ER stress and is an evolutionarily conserved signaling mechanism to overcome stress in the ER, resulting in a pause of new protein synthesis and induction of chaperone proteins to restore normal ER function. Functionally, ER stress and IRE1αv have been linked to alterations in intestinal homeostasis and inflammation. Specifically, ER stress genes are upregulated in intestinal epithelial cells (IECs) from a murine experimental colitis model (IL10-deficient)1 and in IECs or biopsies from inflammatory bowel disease (IBD) patients1,2. IRE1α, as well as other effectors of ER stress, can be initiated by several triggers including high fat diet (HFD) or treatment with saturated FAs, as well as exogenous and endogenous sphingolipids3-5. These important clues in the literature, together with our studies on bioactive sphingolipids in intestinal inflammation, led us to investigate the role of specific dietary FAs in sphingolipid metabolism and their role and mechanism(s) of action in intestinal ER stress. Our very novel observations demonstrate that the C14 saturated FA myristate (rich in milk based diets), but not palmitate (C16 saturated FA), increases ER stress, as well as inflammation in IECs in culture and in mouse intestinal tissues in vivo6. Mechanistically, ceramide synthases 5 and 6 (CerS 5 and 6) are required for the activation of IRE1α branch of the UPR, inducing splicing of XBP1 and expression of IL66. Importantly, these data now lead us to the hypothesis that CerS5/6 and the generation of C14 ceramide regulate IRE1α in the intestine and that this may mediate specific responses in intestinal pathobiology (specifically intestinal inflammation). To test this hypothesis, we propose the following specific aims: Specific Aim 1. Determine the role of CerS5/6 in the regulation of ER stress, specifically IRE1α, in intestinal epithelial cells and intestinal organoids. Specific Aim 2. Define the role of CerS5/6 in ER stress-mediated intestinal pathobiology in vivo.
高脂肪的饮食与肥胖有关,高脂肪饮食(HFD)在改变肠道功能(包括炎症)方面已被浸渍。但是,特定的HFD及其主要脂肪酸(FA)对关键病理生理过程的贡献在很大程度上是未知的。对反脂肪,猪油,橄榄油,鱼油,植物油(玉米油,大豆等)的研究表明,FAS的特定来源在疾病中产生极大的潜水作用,最常见于心脏和代谢疾病。因此,该提案的长期目标是剖析组件的复杂性以及特定饮食FAS对肠道病理生物学的影响,并确定所涉及的机制。具体而言,我们旨在定义两种神经酰胺生成酶,神经酰胺合酶(CERS)5和6的特定作用,在调节肉豆蔻酸酯诱导的肌醇激活中需要酶1α(IRE1α)的激活,并在直肠稳态脑壳膜壳和病理生理学中定义了关键作用。 IRE1α是展开的蛋白质反应(UPR)或ER应激的关键分支,是一种进化保守的信号传导机制,可以克服ER中的应激,从而暂停了新蛋白质合成和链酮蛋白的诱导以恢复正常的ER功能。在功能上,ER应激和IRE1αV与肠内稳态和炎症的改变有关。具体而言,来自鼠实验性结肠炎模型(IL10缺乏症)1,IEC或IEC或活检中的肠上皮细胞(IEC)中的ER应激基因上调1,2。 IRE1α以及ER应激的其他影响可以由多个触发因素(包括高脂饮食(HFD))或用饱和FAS以及外源性和内源性鞘脂3-5进行处理。文献中的这些重要线索以及我们对肠道感染中生物活性鞘脂的研究,使我们研究了特定饮食中Fas在鞘脂代谢中的作用及其作用在肠道ER应激中的作用和机制。我们非常新颖的观察结果表明,C14饱和FA肉豆蔻酸酯(富含牛奶的饮食),但不含棕榈酸酯(C16饱和FA),增加了ER应激,以及IEC在培养物和体内小鼠肠道组织中的炎症。从机械上讲,神经酰胺合成酶5和6(CERS 5和6)激活UPR的IRE1α分支,诱导XBP1的剪接和IL66的表达。重要的是,这些数据现在使我们提出了这样的假设:CERS5/6和C14神经酰胺的产生在肠道中调节IRE1α,并且这可能介导肠道病理学(特别是肠炎症)中的特定反应。为了检验这一假设,我们提出了以下特定目的:特定目的1。确定CERS5/6在肠上皮细胞和肠道器官中ER应激(特别是IRE1α)调节中的作用。具体目的2。定义CERS5/6在体内应力介导的肠道病理生物学中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ashley J. Snider其他文献

Ashley J. Snider的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ashley J. Snider', 18)}}的其他基金

Role for myeloid acid ceramidase in colon inflammation and cancer
髓样酸性神经酰胺酶在结肠炎症和癌症中的作用
  • 批准号:
    10418031
  • 财政年份:
    2022
  • 资助金额:
    $ 33.16万
  • 项目类别:
Role for myeloid acid ceramidase in colon inflammation and cancer
髓样酸性神经酰胺酶在结肠炎症和癌症中的作用
  • 批准号:
    10593982
  • 财政年份:
    2022
  • 资助金额:
    $ 33.16万
  • 项目类别:
Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
鞘脂、膳食脂肪酸和肠道病理生理学
  • 批准号:
    10338567
  • 财政年份:
    2021
  • 资助金额:
    $ 33.16万
  • 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
  • 批准号:
    9975866
  • 财政年份:
    2020
  • 资助金额:
    $ 33.16万
  • 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
  • 批准号:
    10133427
  • 财政年份:
    2020
  • 资助金额:
    $ 33.16万
  • 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
  • 批准号:
    9806440
  • 财政年份:
    2019
  • 资助金额:
    $ 33.16万
  • 项目类别:
SC COBRE: ANIMAL PATHOBIOLOGY CORE
SC COBRE:动物病理学核心
  • 批准号:
    8360379
  • 财政年份:
    2011
  • 资助金额:
    $ 33.16万
  • 项目类别:
SC COBRE: ANIMAL PATHOBIOLOGY CORE
SC COBRE:动物病理学核心
  • 批准号:
    8168044
  • 财政年份:
    2010
  • 资助金额:
    $ 33.16万
  • 项目类别:
The Role of Sphingolipids in Inflammatory Bowel Disease
鞘脂在炎症性肠病中的作用
  • 批准号:
    7749790
  • 财政年份:
    2009
  • 资助金额:
    $ 33.16万
  • 项目类别:
Core C: Sphingolipid Cancer Animal Pathology Core
核心 C:鞘脂癌症动物病理学核心
  • 批准号:
    10020946
  • 财政年份:
    2003
  • 资助金额:
    $ 33.16万
  • 项目类别:

相似海外基金

BCCMA: Overcoming chemoresistance in ovarian cancer: Identification and validation of biomarkers and targetable drivers of platinum resistance
BCCMA:克服卵巢癌的化疗耐药性:铂类耐药的生物标志物和靶向驱动因素的识别和验证
  • 批准号:
    10585641
  • 财政年份:
    2023
  • 资助金额:
    $ 33.16万
  • 项目类别:
Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
鞘脂、膳食脂肪酸和肠道病理生理学
  • 批准号:
    10338567
  • 财政年份:
    2021
  • 资助金额:
    $ 33.16万
  • 项目类别:
Gold-derived therapeutic compounds for disease application
用于疾病应用的金衍生治疗化合物
  • 批准号:
    10180196
  • 财政年份:
    2021
  • 资助金额:
    $ 33.16万
  • 项目类别:
Elucidating structural, mechanistic, and allosteric determinants of mTOR Complex 2 (mTORC2) signaling.
阐明 mTOR 复合物 2 (mTORC2) 信号传导的结构、机制和变构决定因素。
  • 批准号:
    10284076
  • 财政年份:
    2021
  • 资助金额:
    $ 33.16万
  • 项目类别:
Gold-derived therapeutic compounds for disease application
用于疾病应用的金衍生治疗化合物
  • 批准号:
    10461752
  • 财政年份:
    2021
  • 资助金额:
    $ 33.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了